Antibody glycosylation critically modulates immune activation. It changes with age and associates
with inflammatory and metabolic health. This project aims to characterize IgG and IgA glycosylation
profiles in 800 Lifelines participants selected to represent a broad range of chronological and
biological ages, and to examine how these profiles associate with blood-based biomarkers, disease
status, dietary inflammatory index, and lifestyle factors. This work will contribute to the
understanding of immune changes in the context of healthy ageing.
Associations of antibody glycosylation with healthy aging and inflammaging
Year of approval
2026
Institute
Leiden University Medical Center - LUMC
Primary applicant
Falck, D.